Alpna Seth

Track

Insider profile

Currently holds positions in Bio-Techne Corporation and Seagen Inc

Performance

Overall performance
1.3
Performance over holding periods
1.3
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Bio-Techne Corporation Oct. 26, 2017 -
Independent Director Seagen Inc March 15, 2018 -
Alpna Seth's trades of Keros Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
157.69
Quantity 67,955
Value US$1,719,082
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-05 2026-06-04
PlS Planned sale
71,068 +33.3%
401.04
US$3,052,309 		71,068 +33.3% 401.04 US$3,052,309
2026-06-04 2026-06-04
PrS Proposed sale
67,955
157.69
US$1,719,082 		67,955 157.69 US$1,719,082
2020-11-19 2020-11-09
S Sale
26,962 -18.8%
137.41
US$3,174,425 		26,962 -18.8% 137.41 US$3,174,425
2020-11-19 2020-11-09
S Sale
1,358 -19.0%
305.74
US$415,195 		1,358 -19.0% 305.74 US$415,195